9 results
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer … legislation and implemented regulations designed to address pharmaceutical and biological product pricing, including transparency measures
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency … constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed
F-1/A
CNTB
Connect Biopharma Holdings Ltd
18 Mar 21
Registration statement (foreign) (amended)
6:15am
transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program … or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some
F-1/A
obxva7 m9l1ubps
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
3080y0lb 7ou9oazvt
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
uw1 lxfi08sg
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
w88owlg5zz3ozcc4
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next